Biotech Blueprint

Por: Katerina Roznik
Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.

For more content, please subscribe to biotechblueprint.substack.com.
35 episodios disponibles

Latest episodes of the podcast Biotech Blueprint

Mostrando página 2 de 2

Sarepta’s $400M Pivot, MiNK’s 500% Surge, and AML Breakthroughs — This Week in Biotech #61 18/07/2025
CRISPR in 2025: Clinical Use, Regulatory Pressure, and Future Promise 18/07/2025
KalVista’s FDA Win, Merck’s $10B Deal, and CRISPR Momentum — Biotech #60 14/07/2025
Sparks Fly in Biotech — This Week in Biotech #59 03/07/2025
FDA Drama & Psychedelic Setback — This Week in Biotech #58 27/06/2025
HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57 20/06/2025
Biotech Caught Between AI Momentum and Political Turbulence — This Week in Biotech #56 13/06/2025
Navigating Biotech Jobs in 2025: AI, Networking, and Career Strategy 11/06/2025
ASCO Breakthroughs, Gene Therapy Stumbles, and Omada's IPO debut — This Week in Biotech #55 09/06/2025
CRISPR Setbacks, Vaccine Policy Reversed, and an Oral Antibiotic Breakthrough — This Week in Biotech #54 02/06/2025
Organoids, AI, and the FDA’s Move Away from Animal Models 29/05/2025
Tighter Boosters, Novavax's Win, and Psychedelic Signals — This Week in Biotech #53 23/05/2025
Medicare Benchmarking, Novo's Transition, and Biohaven's Setback — This Week in Biotech #52 19/05/2025
CRISPR, Prasad, and the NIH budget bomb — This Week in Biotech #51 11/05/2025
From Wall Street to Wet Lab: Mapping the Future of Biotech 03/05/2025
« Primera ‹ Anterior 1 2
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA